Key Highlights
- Ginkgo Bioworks releases first proprietary protein LLM, trained on exclusive datasets.
- Collaboration with Google Cloud enables AI-driven drug discovery tools.
- Open API allows researchers to access Ginkgo’s machine learning models affordably.
- Chris Sakalosky, Google Cloud praises Ginkgo for democratizing AI tools in life sciences.
Source: Business Wire
Notable Quotes
- “We believe that the low cost for tokens and our customer-friendly terms will allow users to build innovative tools and applications.” — Jason Kelly, CEO at Ginkgo Bioworks
- “Ginkgo’s new protein LLM and open API mark a major step forward in making advanced AI tools accessible for drug discovery.” — Chris Sakalosky, VP of Strategic Industries at Google Cloud
- “Our API comes with competitive pricing and a free tier, empowering users to experiment without high fees.” — Ankit Gupta, General Manager at Ginkgo AI
SoHC's Take
This launch marks a significant milestone in the biotech industry, merging cutting-edge AI with biological research. By partnering with Google Cloud, Ginkgo Bioworks is unlocking new potential for drug discovery and biotechnology innovation. The release of a proprietary protein LLM and an open API demonstrates Ginkgo’s commitment to making advanced research tools more accessible and affordable, a game-changer for pharmaceutical and biotech industries looking to streamline and scale their R&D efforts. The user-friendly pricing model further ensures that even smaller entities can benefit from these sophisticated technologies.
Heading
Key Highlights Jeannette Bankes appointed President & CEO, Patient Care SolutionsEffective May 1, 2025, following Tom Westrick’s retirementBrings 30 years of ...
Key Highlights New AI feature translates everyday language into clinical termsDelivers personalized care guidance with a 99% match rateValidated by ...
Key Highlights Smart Pill Box improves heart medication adherenceIntegrated with Hello Heart app for real-time trackingPersonalized reminders help users avoid ...
Key Highlights SCADE boosts AI performance in genomics with over 96% code execution successTrained on tens of millions of high-quality ...
Key Highlights GE HealthCare joins OR.NET e.V. to advance SDC protocol adoptionSDC enables real-time, secure data exchange between medical devicesSupports ...
Key Highlights Matt Levinappointed CEO of Modern Health, effective immediatelyAlyson Watsontransitions to Executive Chair of the BoardLevin brings 20+ yearsof healthcare and HR ...
